These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3342288)

  • 21. Pharmacokinetics of allopurinol in Dalmatian dogs.
    Ling GV; Case LC; Nelson H; Harrold DR; Johnson DL; Vulliet PR
    J Vet Pharmacol Ther; 1997 Apr; 20(2):134-8. PubMed ID: 9131540
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma pharmacokinetics and bioavailability of 1-(2-chloroethyl)-3-sarcosinamide-1-nitrosourea after intravenous and oral administration to mice and dogs.
    Supko JG; Garcia-Carbonero R; Puchalski TA; Malspeis L
    Cancer Chemother Pharmacol; 2001 Sep; 48(3):202-8. PubMed ID: 11592341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analytical determination and pharmacokinetics of robenacoxib in the dog.
    Jung M; Lees P; Seewald W; King JN
    J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of theophylline in beagle dogs and asthmatic patients after multiple oral doses of sustained-release theophylline tablet formulation.
    Nosaka H; Takagi K; Hasegawa T; Ogura Y; Mizukami Y; Satake T
    Int J Clin Pharmacol Ther Toxicol; 1986 Oct; 24(10):528-35. PubMed ID: 3781672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of TH-302: a hypoxically activated prodrug of bromo-isophosphoramide mustard in mice, rats, dogs and monkeys.
    Jung D; Lin L; Jiao H; Cai X; Duan JX; Matteucci M
    Cancer Chemother Pharmacol; 2012 Mar; 69(3):643-54. PubMed ID: 21964906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of ketorolac after intravenous and oral single dose administration in dogs.
    Pasloske K; Renaud R; Burger J; Conlon P
    J Vet Pharmacol Ther; 1999 Oct; 22(5):314-9. PubMed ID: 10597535
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma nicotine pharmacokinetics in dogs after intravenous administration: determination by radioimmunoassay.
    Monji N; Castro A
    Res Commun Chem Pathol Pharmacol; 1979 Feb; 23(2):267-77. PubMed ID: 461952
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of vinpocetine (Cavinton) in dog.
    Polgár M; Vereczkey L
    Pol J Pharmacol Pharm; 1984; 36(4):407-12. PubMed ID: 6527972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time course of 8-methoxypsoralen concentrations in skin and plasma after topical (bath and cream) and oral administration of 8-methoxypsoralen.
    Tegeder I; Bräutigam L; Podda M; Meier S; Kaufmann R; Geisslinger G; Grundmann-Kollmann M
    Clin Pharmacol Ther; 2002 Mar; 71(3):153-61. PubMed ID: 11907489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of the novel anticonvulsant HEPP after single intravenous administration of three different doses in dogs.
    Gómez LE; Lehmann PA
    Biopharm Drug Dispos; 1995 Mar; 16(2):105-12. PubMed ID: 7780044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of cannabidiol in dogs.
    Samara E; Bialer M; Mechoulam R
    Drug Metab Dispos; 1988; 16(3):469-72. PubMed ID: 2900742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacokinetic studies with atenolol in the dog.
    McAinsh J; Holmes BF
    Biopharm Drug Dispos; 1983; 4(3):249-61. PubMed ID: 6626700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor 2,2,2-trifluoro-1-(3-trimethylsilylphenyl) ethanone in dog. Potential for transdermal patch delivery.
    Dow J; Dulery BD; Hornsperger JM; Di Francesco GF; Keshary P; Haegele KD
    Arzneimittelforschung; 1995 Dec; 45(12):1245-52. PubMed ID: 8595078
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of barnidipine hydrochloride, a new dihydropyridine calcium channel blocker, in the rat, dog and human.
    Teramura T; Watanabe T; Higuchi S; Hashimoto K
    Xenobiotica; 1995 Nov; 25(11):1237-46. PubMed ID: 8592872
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of cefixime after oral and intravenous doses in dogs: bioavailability assessment for a drug showing nonlinear serum protein binding.
    Bialer M; Wu WH; Look ZM; Silber BM; Yacobi A
    Res Commun Chem Pathol Pharmacol; 1987 Apr; 56(1):21-32. PubMed ID: 3589152
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of 5,6-dihydro-5-azacytidine (NSC-264880) in the foxhound.
    Malspeis L; Cheng H; Staubus AE
    Invest New Drugs; 1983; 1(1):47-58. PubMed ID: 6206020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical pharmacokinetics of methoxsalen and other psoralens.
    de Wolff FA; Thomas TV
    Clin Pharmacokinet; 1986; 11(1):62-75. PubMed ID: 3512141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The pharmacokinetics of Casodex in laboratory animals.
    Cockshott ID; Plummer GF; Cooper KJ; Warwick MJ
    Xenobiotica; 1991 Oct; 21(10):1347-55. PubMed ID: 1796611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Food-induced increase in bioavailability of 5-methoxypsoralen.
    Ehrsson H; Wallin I; Ros AM; Eksborg S; Berg M
    Eur J Clin Pharmacol; 1994; 46(4):375-7. PubMed ID: 7957526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modipafant, a new PAF antagonist: pharmacokinetics and disposition in rat, dog and man.
    Jezequel SG; Uden S; Wastall P
    Xenobiotica; 1996 Sep; 26(9):963-75. PubMed ID: 8893043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.